HPX791509_Supplemental_material_CLN.docx (20.16 kB)
HPX791509_Supplemental_material_CLN – Supplemental material for A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs
journal contribution
posted on 2018-08-01, 12:00 authored by Mackenzie Prokes, Adam RootSupplemental material, HPX791509_Supplemental_material_CLN for A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs by Mackenzie Prokes and Adam Root in Hospital Pharmacy